Home/Filings/4/0001209191-24-001135
4//SEC Filing

Aghion Daniel 4

Accession 0001209191-24-001135

CIK 0001176309other

Filed

Jan 7, 7:00 PM ET

Accepted

Jan 8, 4:33 PM ET

Size

6.9 KB

Accession

0001209191-24-001135

Insider Transaction Report

Form 4
Period: 2024-01-04
Transactions
  • Award

    Common Stock

    2024-01-04+5,07035,070 total
  • Award

    Common Stock

    2024-01-04+30,00030,000 total
Footnotes (2)
  • [F1]Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 10,000 shall vest on each of January 1, 2025, January 1, 2026 and January 1, 2027. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
  • [F2]Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of approximately 1,267 on April 1, 2024, July 1, 2024, October 1, 2024 and January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

Entity typeother

Related Parties

1
  • filerCIK 0002004805

Filing Metadata

Form type
4
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 4:33 PM ET
Size
6.9 KB